Figure 5
From: Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
N-Glycan analysis of immunoglobulins (Igs). N-Glycan profiling in Igs was not consistent with that of whole serum N-glycan profiling. The Igs-related N-glycans of m/z 1871 (A), 2337 (B), and 2744 (C) were significantly decreased in the CRPC patients than that of non-CPRC patients. There was no significant difference in the m/z 2890 (D), 3049 (E), 3109 (F), and 3195 (G) between the CRPC and non-CPRC patients. The N-glycans of m/z 3414, and m/z 3719 were not detected on Igs.
